Neurokinin-1 Receptor (NK-1R) Antagonists as a New Strategy to Overcome Cancer Resistance

SIMPLE SUMMARY: Improving the response, quality of life and survival of oncologic patients through the design and application of the most appropriate treatment for each case is a great scientific challenge. Given the role of the axis formed by Substance P (SP) and its preferred receptor neurokinin-1...

Descripción completa

Detalles Bibliográficos
Autores principales: García-Aranda, Marilina, Téllez, Teresa, McKenna, Lauraine, Redondo, Maximino
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9102068/
https://www.ncbi.nlm.nih.gov/pubmed/35565383
http://dx.doi.org/10.3390/cancers14092255

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9102068/
https://www.ncbi.nlm.nih.gov/pubmed/35565383
http://dx.doi.org/10.3390/cancers14092255

Ejemplares similares